CI vs NRIX · P/E 2.4, rev $274.90B vs rev $54.5M
Cigna Corp (CI) versus Nurix Therapeutics Inc (NRIX) — a side-by-side from cached financials, not a winner call.
Cigna Corp (CI) is a healthcare plans company listed on US.
Nurix Therapeutics Inc (NRIX) is a biotechnology company listed on NASDAQ.
Latest reported CI revenue for 2025-12-31 was $274.90B. Net income was $5.96B. Revenue was up 11.2% from 2024-12-31 to 2025-12-31. CI currently screens at market cap $71.62B and trailing P/E 2.4.
Latest reported NRIX revenue for 2024-11-30 was $54.5M. Net income was -$193.6M. Revenue was down 29.1% from 2023-11-30 to 2024-11-30. NRIX currently screens at market cap $1.77B.
CI currently screens at market cap $71.62B and trailing P/E 2.4. NRIX currently screens at market cap $1.77B.
Not investment advice. Open the CI and NRIX stock pages for the full models.
Not investment advice.